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INTRODUCTION
Endoscopic sphincterotomy 
(ES) with stone extraction is 
the recommended standard 
treatment for symptomatic 
choledocholithiasis [1]. However, 
in 10 to 15% of cases, common 
bile duct (CBD) stones are 
difficult to extract by standard 
endoscopic techniques and more 
advanced procedures to achieve 
complete stone clearance might 
be required [2-4].
Endoscopic papillary large-
balloon dilation (EPLBD) with 
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ABSTRACT
Background & Aims: Endoscopic sphincterotomy (ES) with stone extraction is the standard treatment for 
choledocholithiasis. After stone retrieval, balloon-occluded cholangiography is generally performed to confirm 
bile duct clearance but can miss residual stones particularly in patients with residual small-sized stones, a 
large bile duct or pneumobilia. In addition, difficult common bile duct (CBD) stones requiring advanced 
endoscopic techniques for retrieval are a potential risk factor for choledocholithiasis recurrence.
Methods: We performed a retrospective evaluation of a prospectively maintained procedures database. From 
July 2016 to December 2017, all patients with difficult CBD stones who underwent endoscopic retrograde 
cholangiopancreatography (ERCP) with papillary balloon dilation-assisted stone retrieval and subsequent 
direct per-oral cholangioscopy (DPOC) using standard gastroscopes to confirm CBD clearance were analyzed.
Results: Thirty-six patients who underwent ERCP and DPOC were included. Technical success, defined as 
deep intubation of CBD with hepatic hilum visualization, was achieved in 31 of 36 patients (86%). During 
DPOC, residual CBD stones were visualized and removed in 7 of 31 patients (22.5%). After a mean of 241 
± 56 days of follow-up post-DPOC, no serious adverse events were reported, and there was no evidence or 
suspicion of recurrent choledocholithiasis.
Conclusions: Direct per-oral cholangioscopy immediately following difficult CBD stone removal was safe, 
feasible and accurate. In this setting, DPOC at the time of ERCP appears to be a very useful tool to achieve 
complete clearance of choledocholithiasis.
 
Key words: cholangioscopy – ERCP – difficult biliary stones – DPOC. 
Abbreviations: CBD: common bile duct; DASE: dilation-assisted stone extraction; DPOC: direct per-oral 
cholangioscopy; EML: endoscopic mechanical lithotripsy; EPLBD: endoscopic papillary large-balloon 
dilation; ERCP: endoscopic retrograde cholangiopancreatography; ES: endoscopic sphincterotomy; IDUS: 
intraductal ultrasound.
or without ES has been widely considered as an effective and 
safe alternative technique along with endoscopic mechanical 
lithotripsy (EML) for the removal of difficult bile duct stones [5, 
6]. A recent randomized multicenter study demonstrated that 
EPLBD was significantly superior to ES for retrieval of CBD 
stones ≥ 13mm in diameter, reducing the need for mechanical 
lithotripsy [7]. 
Furthermore, difficult bile duct stones are considered a 
risk factor for choledocholithiasis recurrence, recognized 
as a late adverse event after endoscopic retrograde 
cholangiopancreatography (ERCP) [8-10]. As a result, acute 
conditions such as cholangitis and biliary pancreatitis may 
occur and require repeated ERCP examination carrying the 
further risk of iatrogenic adverse events [11-14]. 
After stone retrieval, balloon-occluded cholangiography 
is generally performed to confirm bile duct clearance [15]. 
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However, in patients with residual small-sized stones, a large 
bile duct or pneumobilia, adequate bile duct evaluation may 
be challenging. Even if the stone extraction appears to be 
complete on the cholangiogram, residual stones may still 
remain in the CBD, potentially leading to further long-term 
symptoms and healthcare resource utilization [16]. Tsuchiya 
et al. [17] reported a 23.7% rate of residual CBD stones 
detected by intraductal ultrasound (IDUS) but not seen on 
cholangiography. However, the role of IDUS is limited due to 
probe availability, probe fragility and high procedure costs. 
In recent years, there has been an increasing development 
of through-the-scope cholangioscopy techniques especially 
in the field of large stone management. These instruments 
are principally dedicated to the treatment of difficult biliary 
stones with laser or electrohydraulic lithotripsy, although other 
indications such as the confirmation of bile duct clearance 
at the end of the procedure have been also proposed [18]. 
Nevertheless, due to the high costs, these cholangioscopic 
procedures are usually performed only in specific scenarios, 
not solely for bile duct clearance confirmation. Direct peroral 
cholangioscopy (DPOC) refers to the use of standard upper 
endoscopes for the direct visualization of the biliary tract, 
usually after large ES or EPLBD [19, 20]. 
In this study, we aimed to evaluate the feasibility and safety 
of DPOC to confirm complete CBD clearance after dilation-
assisted CBD stone extraction.
METHODS
This was a retrospective evaluation of a prospectively 
maintained endoscopic procedure database. From July 2016 to 
December 2017, all patients with suggestive features of difficult 
biliary stones (both CBD dilated more than 12 mm and stone 
diameter larger than 10 mm) who underwent ERCP with 
dilation-assisted stone extraction (DASE) followed by DPOC 
were considered eligible for the study. Patients who were under 
the age of 18, pregnant, or critically ill with a pre-operative ASA 
IV score, as well as patients with concomitant cholecystitis or 
undergoing double anti-thrombotic therapy were excluded 
from the analysis. After confirmation of complete stones 
retrieval by a negative occlusive cholangiogram, a DPOC was 
performed using a standard forward-viewing gastroscope. 
The exact choice of gastroscope was at the discretion of the 
endoscopist.
Endoscopic retrograde cholangiopancreatography 
All ERCPs were performed using a duodenoscope (JF 160-
V, Olympus, Tokyo, Japan; or ED-530XT, Fujifilm, Japan) under 
CO2 insufflation. Deep sedation was conducted by anesthetist–
administered propofol-based sedation, with patients generally 
lying in left-lateral position. If performed, ES was achieved 
using a standard pull-type sphincterotome (Autotome or 
Ultratome; Boston Scientific Co. United States). Endoscopic 
papillary large-balloon dilation was carried out using a 
controlled radial expansion balloon (CRE, Boston Scientific 
Corp., Marlborough, United States). A contrast medium at a 1:1 
dilution was generally used for cholangiography (Fig. 1). The 
equipment used to extract the CBD stones included a retrieval 
balloon catheter, a Dormia basket catheter, or a combination of 
both. Mechanical lithotripsy was additionally performed when 
stone extraction proved to be increasingly difficult as a result 
of a large-sized CBD or in the case of disproportion between 
the stone diameter and bile duct caliber below. After stone 
extraction, balloon-occluded cholangiography was performed 
to check for complete clearance of the CBD stones. If any 
residual stones were observed, repeated endoscopic treatments 
were performed until the balloon-occluded cholangiogram 
was negative.
Direct per-oral cholangioscopy 
All of the DPOC procedures were carried out immediately 
after a negative balloon-occluded cholangiography during 
the same endoscopic session. Ultraslim (5.9 mm diameter, 
2.0 mm working channel) or slim (8.5 mm diameter, 2.8 mm 
working channel) endoscopes (FujiFilm EG 530NW or EG 
530FP), or standard gastroscopes (9.9 mm diameter, 2.8 mm 
working channel) (Olympus GIF-HQ190) were inserted via 
the per-oral route to directly access the bile duct, also under 
CO2 insufflation.
Briefly, the endoscope was advanced through the mouth 
down to the second part of the duodenum. Then, at the 
endoscopist’s discretion, the scope was turned into the orifice 
of the major papilla either directly or by means of a guidewire 
(Jagwire 0.035 inch-450 cm, Boston Scientific Co., United 
States) positioned deeply into the intrahepatic biliary tree. 
Then, the endoscope was further advanced into the bile duct 
as far as possible (Fig. 2, 3, 4). Neither balloon catheters, 
nor overtubes or other devices were used for this purpose. 
Technical success was defined as deep intubation of the CBD 
with hepatic hilum visualization. The DPOC time was defined 
as the interval between the endoscope inserting into the mouth 
of the patient up to the end of the procedure.
RESULTS
Patients
Thirty-six patients with difficult CBD stones undergoing 
both DASE and DPOC were included in this study (Table I). 
Fig. 1. Cholangiography: dilated common bile duct 
up to 20 mm and multiple (> 10) stones.
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The mean patient age was 72.4 ± 11.6 years (range, 42-89 years) 
and 20 (55%) of the patients were female. Thirteen patients 
(36%) had a previous cholecystectomy. Twenty patients (55%) 
had an intact papilla (i.e. patients naïve to ERCP and ES), of 
whom two had a medical history of a subtotal gastrectomy 
with Billroth-II anastomosis and one had a peri-diverticular 
position of the papilla. Of the remaining 16 patients, 10 had 
already undergone previous ERCPs and ES with or without 
attempted stone extraction, whilst the remaining 6 studied 
subjects had experienced an ERCP with failed cannulation in 
another center and, as such, were then referred to our institute. 
Fig. 2. Fluoroscopic appearance of direct peroral 
cholangioscopy with the tip of endoscope inside the 
common bile duct (air cholangiography).  
Fig. 3. Hepatic hilum visualization under direct 
peroral cholangioscopy. 
Fig. 4. Stone fragment visualization in the 
distal common bile duct under direct peroral 
cholangioscopy. 
Table I. Patient characteristics
Patients n = 36
Age (years) 72.4 ± 11.6 (range 42-89)
Gender, female n (%) 20 (55%)
ASA score 6 patients ASA 1 
19 patients ASA 2 
11 patients  ASA 3
Intact papilla (patients naïve to ERCP)
Peri-diverticular papilla
Billroth-II gastrectomy
20 patients 
1 patient 
2 patients
Recurrent CBD stones 10 patients
Failed ERCP (referred from other center) 6 patients
CBD: common bile duct; ERCP: endoscopic retrograde cholangio-
pancreatography.
ERCP and DPOC
The results of the ERCP examinations are listed in Table II. 
Stone extraction was carried out by means of retrieval balloon 
catheter, Dormia basket catheter, or a combination of both. 
Mechanical lithotripsy was also performed in two cases. Mean 
procedural time (ERCP including DPOC) was 51 ± 14 minutes. 
Table II. Results of ERCP
Number of CBD stones  
1-2 stones 
3-5 stones  
more than 5 stones
15 patients 
15 patients 
6 patients
Maximum stone diameter 
(mean ± SD)
12.9 ± 3.4 mm (range 10-20 mm)
Maximum CBD diameter CBD 
(mean ± SD)
15.8 ± 3.7 mm (range 12-30 mm)
ES and/or EPLBD 
ES + EPLBD 
EPLBD alone
30 patients 
6 patients
Maximum balloon dilation 
(mean ± SD)
13.4 ± 2.1 mm (range 10-18 mm)
CBD: common bile duct; ES:endoscopic sphincterotomy; EPLBD: 
endoscopic papillary large-balloon dilation
The DPOC results are shown in Table III. Technical success 
was achieved in 31 of 36 patients (86%). Guide-wire assisted 
intubation of CBD was performed in 20 cases (55%), while in 
the remaining 16 cases direct free-hand intubation was utilized. 
The slim endoscope was used in 15 patients, the ultra-slim 
endoscope was used in 12 patients and a standard gastroscope 
in the remaining 9 patients. 
During DPOC, residual CBD stones were found in 7 of 31 
patients (22.5%) in whom the hepatic bifurcation was reached. 
Mean residual stone diameter was 6 ± 1 mm. In 4 patients, the 
residual stones were successfully extracted during per-oral 
cholangioscopy under direct endoscopic visualization using a 
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basket catheter (in 3 cases) or a retrieval device (Roth-Net®, US 
Endoscopy) (in 1 case). In the remaining 3 patients, residual 
stones were removed by using a duodenoscope and standard 
ERCP devices after the cholangioscopy. 
Mean DPOC procedure time was 6.3 ± 2.5 min (range 3-15 
min). No serious procedure-related adverse events (such as 
bleeding, pancreatitis, biliary tract infection or perforation) 
occurred. 
Patients were followed up for a mean 241 ± 56 days after 
the ERCP plus DPOC. At 3- and 6-months post-procedure, all 
subjects underwent outpatient biochemistry and abdominal 
ultrasound evaluation as well as a phone-call interview. During 
this follow-up, there were no patients with either evidence or 
suspicion of recurrent CBD stones. 
DISCUSSION
Endoscopic retrograde cholangiopancreatography 
has been widely accepted as an effective and minimally 
invasive treatment for CBD stones. Nevertheless, in clinical 
practice, acute cholangitis and pancreatitis due to recurrent 
choledocholithiasis occur frequently. Symptomatic recurrent 
CBD stones can occur in 4 to 24% of cases after successful 
endoscopic stone retrieval. Particularly in the case of multiple 
or large CBD stones, small stone fragments which are not 
detectable on the final cholangiogram can remain even after 
apparently complete endoscopic stone removal [21].
Hence, fluoroscopic confirmation of complete bile duct 
clearance after endoscopic treatment may be misleading. 
The most widely used technique is occlusion-balloon 
cholangiography, although different studies have reported that 
it is an imperfect tool in comparison with other modalities 
proposed to deal with this issue (i.e. mother-baby system 
cholangioscopy or IDUS) [16, 17]. 
In recent years, there has been increased development of 
cholangioscopy techniques, devices and applications. Huang et 
al. [19] reported 22.7% of patients having residual CBD stones 
revealed at DPOC performed by means of an ultra-slim scope, 
with an average stone diameter of 3-4 mm. 
In this study, we reported the first retrospective analysis 
of DPOC performed by means of not only ultra-slim, but also 
slim and standard gastroscopes, in order to further evaluate 
clearance of the lower biliary tract after ERCP for difficult 
stones. Our results showed a high CBD intubation rate of 
94% (34 of 36 patients), with a technical success rate, defined 
as direct endoscopic hepatic hilum visualization, of 86% (31 
of 36 patients).
In terms of the rate of unidentified residual stones, our 
results mirror those of previous studies [16, 17, 19]. Our 
rate of undetected residual CBD stones at occlusion-balloon 
cholangiography was 22.5%, with most residual stones/
fragments being of small size, not exceeding 7 mm in diameter. 
It is unclear whether these small residual stones are of clinical 
significance; however, it is conceivable that these residual 
stones might not be excreted after the procedure and may be 
a nidus for stone recurrence and/or cause other long-term 
complications [22].
Meves et al. [23] firstly reported a large series of 100 
patients in whom trans-nasal cholangioscopy was used for 
different diagnostic and therapeutic purposes (evaluation 
of indeterminate biliary strictures, confirmation of CBD 
stone clearance, tumor tissue ablation, etc.) using an ultra-
slim gastroscope; the technical success rate was nearly 81%. 
Nevertheless, this study also clearly showed an important 
drawback of the technique: that access to the CBD is often 
limited and the evaluation of the intrahepatic ducts is feasible 
only in a minority of patients. In a recent study, Lenze et al. 
[24] reported the first clinical experience of DPOC with a new 
anchoring technique using the guide probe of Kautz. Biliary 
access and visualization of the target region were achieved in 
18/20 procedures (90 %). This and subsequent studies often 
reported the feasibility of direct cholangioscopy only by means 
of balloon-anchoring technique, overtube-assisted intubation 
of CBD, or dedicated double-bending tip endoscopes [25-28].
Direct per-oral cholangioscopy does not require anchoring 
or a dedicated cholangioscope, allowing cholangioscopy to be 
performed without additional costs or resources. In our study, 
we showed the safety and efficacy of this method performed 
with commonly available gastroscopes after EPLBD. Most 
importantly, we used a free-hand technique, without the need 
of specifically designed accessories to achieve CBD intubation. 
Direct per-oral cholangioscopy performed with commonly 
available gastroscopes (ultra-slim, slim or standard endoscopes) 
has several advantages over the mother-baby endoscopic 
system. It indeed provides all the functionality of standard 
endoscopes enabling the extraction of residual CBD 
stones during the same endoscopic procedure under direct 
visualization. A basket catheter can pass through the 2-mm 
working channel of the ultra-slim endoscope to grasp residual 
stones. Also, a Roth-Net basket retrieval device can be used in 
the case of an extremely dilated CBD, through a standard 2.8 
mm working channel of slim or standard endoscopes. Secondly, 
it displays superior imaging quality. 
Another encouraging aspect of DPOC is its short 
procedural time. In our cohort, the mean employed time was 
6.3 ± 2.5 min (range 3-15 min), including the supplementary 
extraction procedures performed under direct endoscopic 
view. Considering that the overall mean procedural time was 
51 ± 14 minutes, additional DPOC examination increased it 
by only 10%. In our opinion, this is an acceptable additional 
time in the context of complex ERCP procedures in order to 
Table III. Results of direct per-oral cholangioscopy (DPOC)
Procedure time (mean ± SD) 6.3 ± 2.5 min 
(range, 3-15 min)
Guide-wire assisted intubation of CBD 20 patients (55 %)
Site reached 
Hilum or intrahepatic ducts 
Distal CBD and not visualized hilum 
Failed CBD intubation
31 patients (86 %) 
3 patients (8 %) 
2 patients (6 %)
Residual stones identified 7 patients (22.5 %)
Mean residual stone diameter 6 ± 1 mm
Residual stone(s) treatment 
DPOC 
Dormia basket 
Retrieval Roth-Net  
Standard ERCP techniques
4 cases 
3 cases 
1 case
3 cases
CBD: common bile duct; DPOC: direct per-oral cholangioscopy.
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better evaluate CBD clearance. Therefore, by directly checking 
and confirming the complete clearance of the CBD at the end 
of the ERCP, DPOC could allow significant total cost savings 
for both the procedure itself and potential avoidance of any 
future procedures or healthcare utilization due to retained CBD 
stones. However, we have to bear in mind that this technique 
should be considered as an advanced therapeutic bilio-
pancreatic procedure. As in all other advanced procedures, it 
requires expertise and an adequate background.
In our series, no serious adverse events (such as bleeding, 
pancreatitis, biliary tract infection, or perforation) occurred 
either during the procedures or follow-up period. In addition, 
air embolism, a well-defined adverse event of cholangioscopy, 
was not observed [29]. 
Limitations of this study concern first of all its retrospective 
and non-randomized type alongside the relatively small 
number of patients enrolled. Therefore, it is reasonable to 
consider these results as a preliminary study. In addition to 
this, we arbitrarily considered DPOC as a procedure capable 
of ensuring 100% the presence or absence of stone residual, 
compared to the less performing gold-standard, such as the 
occlusion balloon cholangiogram. Finally, longer follow-up 
may also be required to ascertain that no patient in the DPOC 
group had recurrence of the stones.
CONCLUSION
In the setting of difficult CBD stones, conventional ERCP 
with balloon-occluded cholangiography may not be the most 
reliable or satisfactory method for confirming complete 
bile duct clearance. Alternatively, DPOC using a standard 
endoscope appears to be a very useful and economical tool 
to not only, more confidently confirm the clearance of CBD 
stones, but also to immediately extract any identified residual 
stones/fragments. Our procedure data and relatively long 
recurrence-free follow-up period suggests that DPOC is 
feasible, efficient, accurate and safe in this subgroup of patients 
with difficult CBD stones. Further randomized-controlled 
studies addressing specific primary and secondary outcomes 
are eagerly warranted. 
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